A Phase II Trial of the WEE1 Inhibitor Adavosertib in <i>SETD2</i> <i>-</i> Altered Advanced Solid Tumor Malignancies (NCI 10170)Edward Maldonado, Rahul Aggarwal|Cancer Research Communications|2024Cited by 12